20.13.Z - Manufacture of other inorganic basic chemicals
20.53.Z - Manufacture of chemicals and chemical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.75.Z - Wholesale trade
46.90.Z - Non-specialized wholesale trade
47.91.Z - Intermediary retail sale, non-specialized
47.99.Z - Retail trade
72.20.Z - Scientific research and development in social sciences and humanities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | -4,2 | -0,5 | -0,3 | 27,6 |
Gross profit (loss) | -4,9 | -0,5 | -0,3 | 28 |
EBITDA | -4,1 | -0,5 | -0,3 | 27,6 |
Short time liabilities | 16,2 | 17,2 | 17,3 | 0,4 |
Other operating costs | -0,1 | 0 | 0 | 0 |
Equity capital | -10 | -10,4 | -10,8 | -3,3 |
Operating profit (EBIT) | -4,1 | -0,5 | -0,3 | 27,6 |
Assets | 6,3 | 6,8 | 6,5 | -4,1 |
Net profit (loss) | -4,9 | -0,5 | -0,3 | 28 |
Cash | -0,1 | 0,4 | 0,2 | -62,4 |
Net income from sale | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 16,2 | 17,2 | 17,3 | 0,4 |
Working assets | 6,3 | 6,8 | 6,5 | -4,1 |
Other income costs | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 49,3 | 4,6 | 3,2 | -1,4 |
Equity capital to total assets | -159,4 | -154,3 | -166,2 | -11,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 0.38554346561431885 | 0.3932666480541229 | 0.3755921721458435 | 0 |
Net dept to EBITDA | -0.22764469683170319 | 0.9264035820960999 | 0.48089081048965454 | -0,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane